Medscape reports that as GLP-1 drugs get easier to obtain, some experts worry about misuse, particularly by people with eating disorders.
Recap by typeshit. Post by Medscape on X.
NSW peptide hospitalisations went from five in July 2025 to over 200 in September 2026, and needle programs say syringe machines are emptying within hours.
Bikman says midface volume drops about 7% for every 10 kg lost, and that bariatric surgery patients see the same change.
A woman with bipolar disorder developed tremor and slurred speech three weeks into Zepbound. An outside expert advises checking lithium levels early, not avoiding the drugs.
8:51
Regan Archibald takes on a common question from people using retatrutide: whether the tiredness some report wears off.
Fierce Pharma's weekly tracker, using IQVIA data via Citi and Jefferies, has Zepbound still far ahead at about 801.8K total scripts.
GoodRx keeps a running page on peptide regulation news, with a focus on what the FDA is doing about compounding pharmacies.
Loading…